184 related articles for article (PubMed ID: 24231453)
1. Racial disparity in consultation, treatment, and the impact on survival in metastatic colorectal cancer.
Simpson DR; Martínez ME; Gupta S; Hattangadi-Gluth J; Mell LK; Heestand G; Fanta P; Ramamoorthy S; Le QT; Murphy JD
J Natl Cancer Inst; 2013 Dec; 105(23):1814-20. PubMed ID: 24231453
[TBL] [Abstract][Full Text] [Related]
2. Discrete improvement in racial disparity in survival among patients with stage IV colorectal cancer: a 21-year population-based analysis.
Castleberry AW; Güller U; Tarantino I; Berry MF; Brügger L; Warschkow R; Cerny T; Mantyh CR; Candinas D; Worni M
J Gastrointest Surg; 2014 Jun; 18(6):1194-204. PubMed ID: 24733258
[TBL] [Abstract][Full Text] [Related]
3. Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer.
Nipp R; Tramontano AC; Kong CY; Pandharipande P; Dowling EC; Schrag D; Hur C
Cancer Med; 2018 Feb; 7(2):525-535. PubMed ID: 29322643
[TBL] [Abstract][Full Text] [Related]
4. Racial Differences in Treatment and Survival among Veterans and Non-Veterans with Stage I NSCLC: An Evaluation of Veterans Affairs and SEER-Medicare Populations.
Williams CD; Alpert N; Redding TS; Bullard AJ; Flores RM; Kelley MJ; Taioli E
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):112-118. PubMed ID: 31624076
[TBL] [Abstract][Full Text] [Related]
5. Race and Insurance Differences in the Receipt of Adjuvant Chemotherapy Among Patients With Stage III Colon Cancer.
Murphy CC; Harlan LC; Warren JL; Geiger AM
J Clin Oncol; 2015 Aug; 33(23):2530-6. PubMed ID: 26150445
[TBL] [Abstract][Full Text] [Related]
6. Trends in the multimodality treatment of resectable colorectal liver metastases: an underutilized strategy.
Parikh AA; Ni S; Koyama T; Pawlik TM; Penson D
J Gastrointest Surg; 2013 Nov; 17(11):1938-46. PubMed ID: 24018590
[TBL] [Abstract][Full Text] [Related]
7. Socioeconomic disparities in breast cancer treatment among older women.
White A; Richardson LC; Krontiras H; Pisu M
J Womens Health (Larchmt); 2014 Apr; 23(4):335-41. PubMed ID: 24350590
[TBL] [Abstract][Full Text] [Related]
8. Racial Disparity in Esophageal Squamous Cell Carcinoma Treatment and Survival in the United States.
Noureldin M; Rubenstein JH; Urias E; Berinstein JA; Cohen-Mekelburg S; Saini SD; Higgins PD; Waljee AK
Am J Gastroenterol; 2024 May; 119(5):830-836. PubMed ID: 37975573
[TBL] [Abstract][Full Text] [Related]
9. Social Determinants of Appropriate Treatment for Muscle-Invasive Bladder Cancer.
Washington SL; Neuhaus J; Meng MV; Porten SP
Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1339-1344. PubMed ID: 31092404
[TBL] [Abstract][Full Text] [Related]
10. Examining potential colorectal cancer care disparities in the Veterans Affairs health care system.
Zullig LL; Carpenter WR; Provenzale D; Weinberger M; Reeve BB; Jackson GL
J Clin Oncol; 2013 Oct; 31(28):3579-84. PubMed ID: 24002515
[TBL] [Abstract][Full Text] [Related]
11. Disparities in treatment patterns and mortality in prostate cancer: Interaction between Black race and end-stage kidney disease.
Sarabu N; Dong W; Koroukian SM
Cancer Med; 2024 May; 13(10):e7027. PubMed ID: 38770622
[TBL] [Abstract][Full Text] [Related]
12. The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in Chicago.
Joslin CE; Brewer KC; Davis FG; Hoskins K; Peterson CE; Pauls HA
Gynecol Oncol; 2014 Nov; 135(2):285-91. PubMed ID: 25173584
[TBL] [Abstract][Full Text] [Related]
13. Racial and Ethnic Disparities in Early-Stage Lung Cancer Survival.
Soneji S; Tanner NT; Silvestri GA; Lathan CS; Black W
Chest; 2017 Sep; 152(3):587-597. PubMed ID: 28450031
[TBL] [Abstract][Full Text] [Related]
14. Racial disparities among patients with lung cancer who were recommended operative therapy.
Farjah F; Wood DE; Yanez ND; Vaughan TL; Symons RG; Krishnadasan B; Flum DR
Arch Surg; 2009 Jan; 144(1):14-8. PubMed ID: 19153319
[TBL] [Abstract][Full Text] [Related]
15. Ethnic Disparities in Imaging Utilization at Diagnosis of Non-Small Cell Lung Cancer.
Morgan RL; Karam SD; Bradley CJ
J Natl Cancer Inst; 2020 Dec; 112(12):1204-1212. PubMed ID: 32134453
[TBL] [Abstract][Full Text] [Related]
16. Referral patterns between high- and low-volume centers and associations with uterine cancer treatment and survival: a population-based study of Medicare, Medicaid, and privately insured women.
Doll KM; Meng K; Gehrig PA; Brewster WR; Meyer AM
Am J Obstet Gynecol; 2016 Oct; 215(4):447.e1-447.e13. PubMed ID: 27130238
[TBL] [Abstract][Full Text] [Related]
17. Healthcare Access Dimensions and Guideline-Concordant Ovarian Cancer Treatment: SEER-Medicare Analysis of the ORCHiD Study.
Montes de Oca MK; Wilson LE; Previs RA; Gupta A; Joshi A; Huang B; Pisu M; Liang M; Ward KC; Schymura MJ; Berchuck A; Akinyemiju TF
J Natl Compr Canc Netw; 2022 Nov; 20(11):1255-1266.e11. PubMed ID: 36351338
[TBL] [Abstract][Full Text] [Related]
18. Treatment and survival differences in older Medicare patients with lung cancer as compared with those who are dually eligible for Medicare and Medicaid.
Bradley CJ; Dahman B; Given CW
J Clin Oncol; 2008 Nov; 26(31):5067-73. PubMed ID: 18794546
[TBL] [Abstract][Full Text] [Related]
19. Multiple mediation analysis with survival outcomes: With an application to explore racial disparity in breast cancer survival.
Yu Q; Wu X; Li B; Scribner RA
Stat Med; 2019 Feb; 38(3):398-412. PubMed ID: 30255567
[TBL] [Abstract][Full Text] [Related]
20. Racial Disparities in Recurrence and Overall Survival in Patients With Locoregional Colorectal Cancer.
Snyder RA; Hu CY; Zafar SN; Francescatti A; Chang GJ
J Natl Cancer Inst; 2021 Jun; 113(6):770-777. PubMed ID: 33231683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
